Trademark: GENE REWRITING
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for GENE REWRITING
We do not have any records of a proof of use for GENE REWRITING at this moment.
Possible trademark infringements of GENE REWRITING
Basic Information about GENE REWRITING
- Serial Number
- 88921526
- Filing Date
- 18 May 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of GENE REWRITING on the blockchain with WikiTrademarks.io.
- First use of GENE REWRITING anywhere
- GENE REWRITING was first used on 07 Sep 2021 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns GENE REWRITING?
1. Tessera Therapeutics, Inc. Somerville MA
Correspondent
- Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
- 600 ATLANTIC AVENUE
- BOSTON, MA 02210-2206
- UNITED STATES
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io